Dopaminergic impairment and neuroinflammation in Parkinson's disease

被引：0
|
作者：
Ouchi, Yasuomi [1 ]
机构：
[1] Hamamatsu Univ Sch Med, Mol Imaging Res Ctr, Hamamatsu, Shizuoka 4313192, Japan
来源：
JOURNAL OF PHARMACOLOGICAL SCIENCES | 2008年 / 106卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：22P / 22P
页数：1
相关论文
共 50 条
  • [21] Non-dopaminergic treatment of cognitive impairment and dementia in Parkinson's disease: A review
    Leroi, Iracema
    Collins, Deborah
    Marsh, Laura
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2006, 248 (1-2) : 104 - 114
  • [22] Motor impairment, in patients with severe Parkinson's disease, associated with dopaminergic hyperstimulation (entacapone)
    Vaamonde, J
    Ibáñez, R
    Hernández, A
    Gudín, M
    de Luis, P
    del Real, MA
    NEUROLOGIA, 2001, 16 (02): : 81 - 84
  • [23] Influence of dopaminergic medication on automatic postural responses and balance impairment in Parkinson's disease
    Bloem, BR
    Beckley, DJ
    vanDijk, JG
    Zwinderman, AH
    Remler, MP
    Roos, RAC
    MOVEMENT DISORDERS, 1996, 11 (05) : 509 - 521
  • [24] Parkinson's disease and dopaminergic neurons
    Neural Regeneration Research, 2012, (05) : 368 - 368
  • [25] Dopaminergic agonists in Parkinson's disease
    Alonso Canovas, A.
    Luquin Piudo, R.
    Garcia Ruiz-Espiga, P.
    Burguera, J. A.
    Campos Arillo, V.
    Castro, A.
    Linazasoro, G.
    Lopez del Val, J.
    Vela, L.
    Martinez Castrillo, J. C.
    NEUROLOGIA, 2014, 29 (04): : 230 - 241
  • [26] Mitoapocynin Treatment Protects Against Neuroinflammation and Dopaminergic Neurodegeneration in a Preclinical Animal Model of Parkinson's Disease
    Ghosh, Anamitra
    Langley, Monica R.
    Harischandra, Dilshan S.
    Neal, Matthew L.
    Jin, Huajun
    Anantharam, Vellareddy
    Joseph, Joy
    Brenza, Timothy
    Narasimhan, Balaji
    Kanthasamy, Arthi
    Kalyanaraman, Balaraman
    Kanthasamy, Anumantha G.
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2016, 11 (02) : 259 - 278
  • [27] FGF21 Protects Dopaminergic Neurons in Parkinson's Disease Models Via Repression of Neuroinflammation
    Fang, Xingxing
    Ma, Jinyu
    Mu, Dengcai
    Li, Bing
    Lian, Bolin
    Sun, Cheng
    NEUROTOXICITY RESEARCH, 2020, 37 (03) : 616 - 627
  • [28] FGF21 Protects Dopaminergic Neurons in Parkinson’s Disease Models Via Repression of Neuroinflammation
    Xingxing Fang
    Jinyu Ma
    Dengcai Mu
    Bing Li
    Bolin Lian
    Cheng Sun
    Neurotoxicity Research, 2020, 37 : 616 - 627
  • [29] Mechanism of miR-132-3p Promoting Neuroinflammation and Dopaminergic Neurodegeneration in Parkinson's Disease
    Gong, Xin
    Huang, Mengyi
    Chen, Lei
    ENEURO, 2022, 9 (01) : 1 - 17
  • [30] CNI-1493 attenuates neuroinflammation and dopaminergic neurodegeneration in the MPTP mouse model of Parkinson's disease
    Noelker, C.
    Stuckenholz, V.
    Reese, J. P.
    Alvarez-Fischer, D.
    Sankowski, R.
    Dodel, R. C.
    Oertel, W. H.
    Hartmann, A.
    van Patten, S.
    Al-Abed, Y.
    Bacher, M.
    MOVEMENT DISORDERS, 2012, 27 : S47 - S47
12345